Nextage Therapeutics Ltd (TLV:NXTG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 94.80
+0.20 (0.21%)
Feb 20, 2025, 5:14 PM IDT
Nextage Therapeutics Market Cap
Nextage Therapeutics has a market cap or net worth of 34.28 million as of February 21, 2025. Its market cap has increased by 211.43% in one year.
Market Cap
34.28M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
94.80
Market Cap Chart
Since August 31, 2020, Nextage Therapeutics's market cap has decreased from 110.42M to 34.28M, a decrease of -68.96%. That is a compound annual growth rate of -23.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 34.28M | 29.59% |
| Dec 31, 2024 | 26.45M | 168.30% |
| Dec 31, 2023 | 9.86M | -39.56% |
| Dec 29, 2022 | 16.31M | -71.75% |
| Dec 30, 2021 | 57.75M | -26.29% |
| Dec 31, 2020 | 78.35M | -29.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 69.73B |
| Danel (Adir Yeoshua) | 2.53B |
| Kamada | 1.59B |
| Bait Bakfar | 1.07B |
| Novolog (Pharm-Up 1966) | 907.03M |
| Ilex Medical | 800.59M |
| BrainsWay | 762.81M |
| SofWave Medical | 597.96M |